Hepatitis B Vaccine Trial Withholding Doses from African Newborns Approved in Guinea-Bissau
Source Summary
A controversial research trial led by Danish researchers that will withhold hepatitis B vaccine doses from some newborns in Guinea-Bissau has been approved to proceed. The trial is aligned with vaccine policy positions held by Robert F. Kennedy Jr., who now serves as secretary of the US Department of Health and Human Services.
Why it matters
The trial's approval represents a significant shift in vaccine policy implementation, given Kennedy's prominent role in US health policy and his longstanding opposition to standard vaccination protocols.
What remains uncertain
The source does not specify the full scope of the trial design, the number of newborns affected, or the stated scientific rationale for withholding hepatitis B vaccine doses.
